TAGS: A phase III, randomised, double-blind study of trifluridine/tipiracil (TAS-102) versus placebo in patients with refractory metastatic gastric cancer Meeting Abstract


Authors: Arkenau, H. T.; Tabernero, J.; Shitara, K.; Dvorkin, M.; Mansoor, W.; Prokharau, A.; Alsina, M.; Ghidini, M.; Faustino, C.; Gorbunova, V.; Zhavrid, E. A.; Nishikawa, K.; Hosokawa, A.; Ganea, D.; Yalçın, Ş.; Beretta, G. D.; Winkler, R. E.; Makris, L.; Doi, T.; Ilson, D. H.
Abstract Title: TAGS: A phase III, randomised, double-blind study of trifluridine/tipiracil (TAS-102) versus placebo in patients with refractory metastatic gastric cancer
Meeting Title: 43rd ESMO Congress (ESMO 2018)
Journal Title: Annals of Oncology
Volume: 29
Issue: Suppl. 8
Meeting Dates: 2018 Oct 19-23
Meeting Location: Munich, Germany
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2018-10-01
Start Page: mdy424.027
Language: English
ACCESSION: WOS:000459277304383
PROVIDER: wos
DOI: 10.1093/annonc/mdy424.027
Notes: Meeting Abstract: LBA25 -- Appears on page viii718 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David H Ilson
    436 Ilson